The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II study of apalutamide with or without carotuximab (ant-CD105) in metastatic, castration-resistant prostate cancer.
 
Edwin Melencio Posadas
Consulting or Advisory Role - Bayer; CytoLumina; Myovant Sciences
Speakers' Bureau - Bayer
Research Funding - PFizer
Patents, Royalties, Other Intellectual Property - Patent on NanoVelcro Assay for CTCs in prostate cancer
 
Umang Swami
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Exelixis; Imvax; Sanofi; Seagen
Research Funding - Exelixis (Inst); Janssen (Inst); Seattle Genetics/Astellas (Inst)
 
Tanya B. Dorff
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bayer; Exelixis; Janssen Oncology; Pfizer; Sanofi/Aventis; Seagen
Research Funding - Pfizer (Inst)
 
Mourad Tighiouart
No Relationships to Disclose
 
Jasmine Jiemei Wang
No Relationships to Disclose
 
Yazhen Zhu
No Relationships to Disclose
 
Hsian-Rong Tseng
Leadership - CytoLumina
Patents, Royalties, Other Intellectual Property - NanoVelcro
 
Manish Kohli
Employment - nference (I)
Honoraria - Advanced Accelerator Applications
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Genapsys; Tempus
Patents, Royalties, Other Intellectual Property - Patent number: 10982286. Algorithmic approach for determining the plasma genome abnormality PGA and the urine genome abnormality UGA scores based on cell free cfDNA copy number variations in plasma and urine
Travel, Accommodations, Expenses - Celgene
 
Dolores Di Vizio
Patents, Royalties, Other Intellectual Property - Cedars Sinai/ EV Diagnostics
 
Neil Bhowmick
Stock and Other Ownership Interests - Bristol-Myers Squibb; Fibrobiologics; Pfizer
Consulting or Advisory Role - Fibrobiologics
Research Funding - Xencor
Patents, Royalties, Other Intellectual Property - Cedars Sinai
(OPTIONAL) Uncompensated Relationships - Bristol-Myers Squibb